Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] A novel total artificial heart: search for haemocompatibility

During the past four decades several groups in the USA and Europe have developed and clinically implemented different cardiac prostheses or total artificial hearts (TAH)—the Cooley/Liotta TAH, Jarvik7 TAH, Bücherl Heart TAH, AbioCor TAH, and CardioWest TAH (TAH-t), which is currently in use. The aim of TAHs is to mimic native heart anatomy and function, fitting into the pericardial cavity and providing pulsatile unidirectional blood flow from the atria to the great arteries in patients with end-stage biventricular heart failure.

email